Skip to main content

Table 2 Enrolled patients’ characteristics

From: Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer

Characteristic

No of patients

(N = 21)

%

Age (years)

 

 Median

67

 Range

43–75

Sex

  

 Male

8

38

 Female

13

62

ECOG performance status

  

 0

21

100

 1

0

0

CA 19–9 at diagnosis, U/mL

 

 Median

1028,15

 Range

0–6688

Tumor localization

  

 Head

21

100

 Body/Tail

0

0

Resectability status

  

 Borderline resectable

3

14

 Unresectable

18

86